Mirion Technologies, Inc. (NYSE:MIR) Stock Holdings Lessened by First Trust Advisors LP

First Trust Advisors LP trimmed its position in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 58.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 109,257 shares of the company's stock after selling 155,689 shares during the quarter. First Trust Advisors LP's holdings in Mirion Technologies were worth $1,907,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. US Bancorp DE raised its position in Mirion Technologies by 3,248.7% in the 4th quarter. US Bancorp DE now owns 6,262 shares of the company's stock valued at $109,000 after purchasing an additional 6,075 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new stake in shares of Mirion Technologies during the 4th quarter valued at approximately $120,000. KBC Group NV boosted its position in Mirion Technologies by 39.2% during the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock worth $140,000 after purchasing an additional 2,254 shares in the last quarter. Corient Private Wealth LLC purchased a new stake in shares of Mirion Technologies in the 4th quarter worth about $187,000. Finally, Longboard Asset Management LP purchased a new stake in shares of Mirion Technologies in the fourth quarter valued at about $202,000. 78.51% of the stock is currently owned by institutional investors and hedge funds.

Mirion Technologies Stock Up 1.7%

Shares of MIR traded up $0.28 during trading on Friday, reaching $16.41. The company's stock had a trading volume of 947,349 shares, compared to its average volume of 1,689,368. Mirion Technologies, Inc. has a twelve month low of $9.11 and a twelve month high of $18.81. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. The company has a market cap of $3.81 billion, a price-to-earnings ratio of -86.37 and a beta of 0.74. The company has a fifty day moving average of $14.61 and a two-hundred day moving average of $15.76.

Mirion Technologies (NYSE:MIR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.02. The firm had revenue of $202.00 million for the quarter, compared to the consensus estimate of $199.34 million. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The firm's revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.06 EPS. On average, sell-side analysts predict that Mirion Technologies, Inc. will post 0.39 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently commented on MIR shares. B. Riley dropped their price objective on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a research report on Wednesday, April 16th. Robert W. Baird lowered their price target on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, April 4th. Finally, Citigroup cut their price objective on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $18.75.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.